HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
RecruitingNCT06626789

Amygdala neurofeedback for Borderline Personality Disorder

The registry lists this study as recruiting. Study locations are listed in Germany. Confirm recruitment at each site. It is testing amygdala neurofeedback for Borderline Personality Disorder.

Personality disorders, Borderline personalityBehavioralFrom 18 Years to 65 Years
In plain English

Key information made simple

What is this study testing?

This study is testing whether imaging scans may be useful for adults experiencing personality disorders.

What would participation involve?

Participants may complete imaging scans, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Germany.

Who is it mainly for?

This study appears to be mainly for adults with personality disorders.

What should you check before joining?

Ask about whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: April 23, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
164
Sponsor
Central Institute of Mental Health, Mannheim
Sponsor type
Research institute
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, BIOLOGICAL
Study phase
Phase 1, Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Germany
Age range
From 18 Years to 65 Years
Official registry ID
NCT06626789
Official title
A Multi-center, Patient-blinded and Investigator-blinded, Randomized, Parallel-group, Superiority Study to Compare the Efficacy of Four Sessions of Amygdala fMRI-BOLD Neurofeedback With Yoked Sham-control Neurofeedback in the Treatment of Dysregulated Affect in Borderline Personality Disorder

Want help reviewing this study?

Loading the security check...
Study ID: NCT06626789. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Recruiting

Freiburg im Breisgau · Giessen · Halle

3 more locations
  • Hamburg
  • Mannheim
  • Tübingen
Checked Official study record (opens in a new tab)
Registry details
Registry conditions (original wording)

Borderline Personality Disorder

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Central Institute of Mental Health, Mannheim, a research institute.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.